The US food and drug administration’s approval of adjuvant sunitinib for renal cell cancer: A case of regulatory capture?

Bishal Gyawali; Daniel A. Goldstein

doi:10.1001/jamaoncol.2017.5697

The US food and drug administration’s approval of adjuvant sunitinib for renal cell cancer: A case of regulatory capture?

^*Corresponding author for this work

Research output: Contribution to journal › Comment/debate

Original language	English
Pages (from-to)	623-624
Number of pages	2
Journal	JAMA Oncology
Volume	4
Issue number	5
DOIs	https://doi.org/10.1001/jamaoncol.2017.5697
State	Published - May 2018
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1001/jamaoncol.2017.5697

Cite this

@article{15bd4102ea604a09a57d97909cb37c6c,

title = "The US food and drug administration{\textquoteright}s approval of adjuvant sunitinib for renal cell cancer: A case of regulatory capture?",

author = "Bishal Gyawali and Goldstein, {Daniel A.}",

year = "2018",

month = may,

doi = "10.1001/jamaoncol.2017.5697",

language = "אנגלית",

volume = "4",

pages = "623--624",

journal = "JAMA Oncology",

issn = "2374-2437",

publisher = "American Medical Association",

number = "5",

}

TY - JOUR

T1 - The US food and drug administration’s approval of adjuvant sunitinib for renal cell cancer

T2 - A case of regulatory capture?

AU - Gyawali, Bishal

AU - Goldstein, Daniel A.

PY - 2018/5

Y1 - 2018/5

UR - http://www.scopus.com/inward/record.url?scp=85047476747&partnerID=8YFLogxK

U2 - 10.1001/jamaoncol.2017.5697

DO - 10.1001/jamaoncol.2017.5697

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.comment???

C2 - 29522146

AN - SCOPUS:85047476747

SN - 2374-2437

VL - 4

SP - 623

EP - 624

JO - JAMA Oncology

JF - JAMA Oncology

IS - 5

ER -

The US food and drug administration’s approval of adjuvant sunitinib for renal cell cancer: A case of regulatory capture?

UN SDGs

Access to Document

Other files and links

Cite this